Rosetta Genomics and the Medical Dilemma of CUP
February 4, 2013
It’s a disease medical science has been battling for years. Cancer continues to claims millions of lives in the United States. But a cutting-edge technology, called MicroRNA Testing, hold promise in our collective effort to identify tumor origins. Tune-in to The Balancing Act as they discuss where this technology is…where it may be going…and how it’s helping patients and doctors defeat this dreaded disease.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.